THE OVARIAN CANCER RESEARCH FUND INC

EIN: 133806788 501(c)(3) Philanthropy & Grantmaking

NEW YORK, NY

Total Revenue
$13,442,515
Total Expenses
$13,752,760
Total Assets
$39,203,357
Net Assets
$24,483,064
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1994
Legal Domicile
NY
Principal Officer
AUDRA L MORAN
Phone
2122681002
Tax Period
2023-01-01 to 2023-12-31

THE OVARIAN CANCER RESEARCH FUND INC, founded in 1994, is a mid-sized nonprofit in the Philanthropy & Grantmaking sector that reported $13.4M in total revenue in fiscal year 2023. Revenue decreased 18% compared to the prior year.

Mission

OVARIAN CANCER RESEARCH ALLIANCE IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $11,556,311
Program Service Revenue $438,937
Investment Income $1,447,267
Other Revenue $0
TOTAL REVENUE $13,442,515

Expense Breakdown

Grants Paid $8,117,910
Salaries & Benefits $3,064,716
Fundraising Expenses $1,415,702
Program Expenses $11,116,441
Other Expenses $2,570,134
TOTAL EXPENSES $13,752,760

Year-over-Year Comparison

2023 2022 Change
Revenue $13,442,515 $16,425,940 -0.2%
Expenses $13,752,760 $11,462,650 +0.2%
Net Income $-310,245 $4,963,290 -1.1%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
19
Independent Members
19
Employees
30
Volunteers
4007

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
6
$576,063
Total Directors
19
$0
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOHN ORRICO CHAIR 3.00
Officer Director
$0 $0 $0
MATTHEW NEAL MILLER VICE PRESIDENT 2.00
Officer Director
$0 $0 $0
MARK TESSAR TREASURER 2.00
Officer Director
$0 $0 $0
ROBIN S COHEN SECRETARY 2.00
Officer Director
$0 $0 $0
JEANNETTE CHANG DIRECTOR 1.00
Director
$0 $0 $0
DR CARMEL J COHEN DIRECTOR 1.00
Director
$0 $0 $0
MEI-LI DA SILVA VINT ESQ DIRECTOR 1.00
Director
$0 $0 $0
ANDREW FEUERSTEIN DIRECTOR 1.00
Director
$0 $0 $0
CAROL J HAMILTON DIRECTOR 1.00
Director
$0 $0 $0
JOHN W HANSBURY ESQ DIRECTOR 1.00
Director
$0 $0 $0
CAROLINE HIRSCH DIRECTOR 1.00
Director
$0 $0 $0
VERONICA JORDAN DIRECTOR 1.00
Director
$0 $0 $0
THOMAS C LIEBMAN DIRECTOR 1.00
Director
$0 $0 $0
DANA L MARK ESQ DIRECTOR 1.00
Director
$0 $0 $0
YLAIN G MAYER DIRECTOR 1.00
Director
$0 $0 $0
CHRIS NEWCOMB DIRECTOR 1.00
Director
$0 $0 $0
LISA SCHREIBER DIRECTOR 1.00
Director
$0 $0 $0
ELLE SIMONE SCOTT DIRECTOR 1.00
Director
$0 $0 $0
CHRISTOPHER TILBERIS DIRECTOR 1.00
Director
$0 $0 $0
AUDRA L MORAN PRESIDENT & CEO 40.00
Officer
$312,816 $32,894 $345,710
BIBI ALI CHIEF FINANCIAL OFFICER 40.00
Officer
$202,842 $27,511 $230,353
JONATHAN ZEIDMAN CHIEF DEVELOPMENT OFFICER 40.00
Highest
$204,750 $28,594 $233,344
SARAH DEFEO CHIEF PROGRAM OFFICER 40.00
Highest
$183,750 $36,476 $220,226
TRACY MOORE VP - SUPPORT & EDUCATION 40.00
Highest
$152,500 $25,979 $178,479
NICOLE WARGO VP - PHILANTHROPIC PARTNER 40.00
Highest
$128,823 $25,316 $154,139
CHAD RAMSEY VP - POLICY 40.00
Highest
$119,107 $24,535 $143,642
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $13,442,515 $13,752,760 $39,203,357 $-310,245
2023 No data No data No data No data
2022 $16,425,940 $11,462,650 $37,659,088 $4,963,290
2021 $13,088,201 $11,092,931 $32,985,153 $1,995,270
2020 $7,726,766 $8,360,005 $29,388,979 $-633,239
2019 $8,409,768 $10,684,965 $30,448,674 $-2,275,197
2018 $9,721,559 $11,054,168 $28,825,539 $-1,332,609
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare THE OVARIAN CANCER RESEARCH FUND INC with other nonprofits in New York and across the country.